Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Ohio State University |
---|---|
Information provided by: | Ohio State University |
ClinicalTrials.gov Identifier: | NCT00815711 |
To establish a registry olf patients for furutre studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.
Condition |
---|
Lung Disease, Interstitial Idiopathic Pulmonary Fibrosis |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis |
blood serum BAL fluid lung biopsy
Estimated Enrollment: | 84 |
Study Start Date: | December 2008 |
Estimated Study Completion Date: | January 2015 |
Estimated Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |
To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated. Having a bank of samples that are correlated with physciologic measures that follow patients through their course will allow the followign proposed studies as well as future investigations to be efficiently carried out.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
primary care clinic
Inclusion Criteria:
Exclusion Criteria:
Contact: Janice E Drake, CRTT | 614-688-2287 | janice.drake@osumc.edu |
Contact: Sharon T Cheung, BS | 614-366-2258 | sharon.cheung@osumc.edu |
United States, Ohio | |
The Ohio State University | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Janice E Drake, CRTT | |
Sub-Investigator: James N Allen, MD | |
Sub-Investigator: Nitin Y Bhatt, MD | |
Sub-Investigator: Christopher Baran, PhD |
Principal Investigator: | Clay B Marsh, MD | Ohio State University |
Responsible Party: | The Ohio State University ( Clay Marsh, MD ) |
Study ID Numbers: | 2007H0002 |
Study First Received: | December 29, 2008 |
Last Updated: | December 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00815711 |
Health Authority: | United States: Institutional Review Board |
IPF |
Lung Diseases, Interstitial Respiratory Tract Diseases Fibrosis Hamman-Rich syndrome |
Lung Diseases Pulmonary Fibrosis Inflammation |
Pathologic Processes |